Media

Brandon Newman, CEO of Xevant, has a dynamic, 25-year career as a business leader and innovator spearheading several businesses in the Healthcare space with emphasis on growth, revenue, and sales performance. He has run multiple high-growth environments including start-ups, turnarounds, and $1B+ dollar global businesses.

In lieu of an in-person event this year, Utah Business partnered with Kiln, Roseman University of Health Science, Intermountain Healthcare, Merit Medical, and Xevant to talk to some of our state’s top healthcare executives about Covid two years in and where we are going in the future. Hosted by Elle Griffin, editor-in-chief of Utah Business, today’s panelists are Jeremy Wells, chancellor at Roseman University; Brandon Newman, co-founder and CEO of Xevant; Katelin Roberts, executive director at BioHive; Lori Weston, CEO of Park City Hospital; and Nicole Priest, chief wellness officer at Merit Medical.

Brandon Newman has a dynamic, 30-year leadership career spearheading several health technology businesses with an emphasis on growth, revenue, and operational excellence. He has run many high-growth environments, including start-ups, turnarounds, and $1B+ dollar businesses. As a serial entrepreneur, he has a proven record of founding new businesses and advancing them through growth and acquisition, merger, or roll-up including ScripPoint, Veridian, and AviaraMD.

In the modern digital era of business, the outreach of technological advancements and innovation continues to grow to change the dynamics of all industries. In healthcare, these technological developments have started to play a vital role for customers and enterprises alike. Devices like smartphones and tablets have replaced orthodox monitoring and recording systems due to their higher efficiency, precision, and faster troubleshooting ability.

In the modern digital era of business, the outreach of technological advancements and innovation continues to grow to change the dynamics of all industries. In healthcare, these technological developments have started to play a vital role for customers and enterprises alike. Devices like smartphones and tablets have replaced orthodox monitoring and recording systems due to their higher efficiency, precision, and faster troubleshooting ability.

Pharmacy benefits is a complex environment and using the traditional, decades-old playbook to manage pharmacy benefits performance is daunting. There are 100,000+ drugs and drug formulations, 70,000+ pharmacies, 1M+ providers, and 100M+ patients all with perceived competing priorities. No big deal, right? In reality, with technological advances we can toss the old playbook of running and analyzing reports in favor of the new rules for boosting pharmacy benefits optimization by leveraging: 1) Big Data, 2) Analytics Automation, and 3) Alert-based Action.

Brandon has a dynamic, 25-year leadership career spearheading several businesses with emphasis on growth, revenue, and sales performance. He has run many high-growth environments, including start-ups, turnarounds, and $1B+ dollar businesses. As a serial entrepreneur, he has a proven record of founding new businesses and advancing them through growth and acquisition, merger, or roll-up including ScripPoint, Veridian, and AviaraMD. He is the driving force for vision, new market strategy, revenue growth, technology development, and partner alliances.

Sramana Mitra: Let’s start by introducing our audience to yourself and Xevant.
Brandon Newman: I’m the CEO and Co-Founder of Xevant. I have personally been a part of the pharmacy benefits and the broader healthcare technology industry for nearly 30 years in solving some of the ongoing needs that are facing healthcare such as increasing costs, changes in therapy, and changes in how employers and other players across the US manage costs in healthcare.